Cancer Cell
Volume 18, Issue 3, 14 September 2010, Pages 282-293
Journal home page for Cancer Cell

Article
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21

https://doi.org/10.1016/j.ccr.2010.08.013Get rights and content
Under an Elsevier user license
open archive

Summary

Lung cancer is the leading cause of cancer-related deaths in the world, and non-small-cell lung cancer (NSCLC) accounts for 80% of cases. MicroRNA-21 (miR-21) expression is increased and predicts poor survival in NSCLC. Although miR-21 function has been studied in vitro with cancer cell lines, the role of miR-21 in tumor development in vivo is unknown. We utilize transgenic mice with loss-of-function and gain-of-function miR-21 alleles combined with a model of NSCLC to determine the role of miR-21 in lung cancer. We show that overexpression of miR-21 enhances tumorigenesis and that genetic deletion of miR-21 partially protects against tumor formation. MiR-21 drives tumorigenesis through inhibition of negative regulators of the Ras/MEK/ERK pathway and inhibition of apoptosis.

Highlights

► miR-21 overexpression promotes tumorigenesis in a mouse model of NSCLC ► miR-21 deletion suppresses tumorigenesis in a mouse model of NSCLC ► miR-21 targets multiple suppressors of Ras signaling enhancing proliferation ► miR-21 suppresses apoptosis by targeting proapoptotic genes enhancing survival

Cited by (0)

4

Present address: miRagen Therapeutics, Boulder, CO 80301-3695, USA